CD44 and neoplasm: We observed a significant increase in CD44 and OCT3/4 levels in Delta16HER2/SIRT6-OE tumor bulk over Delta16HER2 both in terms of median fluorescence intensity (MFI) (Fig. 4A), and population frequency (Fig. 4B–D).